How frequently does hepatocellular carcinoma develop in at-risk patients with a negative liver MRI examination with intravenous Gadobenate dimeglumine?-Reference-Cited by-同舟云学术

How frequently does hepatocellular carcinoma develop in at-risk patients with a negative liver MRI examination with intravenous Gadobenate dimeglumine?

Published:2020-09-19 Issue:3 Volume:46 Page:969-978
ISSN:2366-004X
Container-title:Abdominal Radiology
language:en
Short-container-title:Abdom Radiol

Author:

Zaki Islam H.,Shropshire Erin,Zhang Shuaiqi,Xiao Dong,Wildman-Tobriner Benjamin,Marin Daniele,Gupta Rajan T.,Erkanli Alaattin,Nelson Redon C.,Bashir Mustafa R.

Publisher

Springer Science and Business Media LLC

Subject

Urology,Gastroenterology,Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

https://link.springer.com/content/pdf/10.1007/s00261-020-02771-5.pdf

Reference33 articles.

1. Bray, F., et al., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 2018. 68(6): p. 394–424.

2. Ghouri, Y., I. Mian, and J. Rowe, Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis. Journal of Carcinogenesis, 2017. 16(1): p. 1–1.

3. Lai, E.C., et al., Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Annals of surgery, 1995. 221(3): p. 291–298.

4. Marrero, J.A., et al., Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology, 2018. 68(2): p. 723–750.

5. Trinchet, J.-C., et al., Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities. Hepatology, 2011. 54(6): p. 1987–1997.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic performance of US LI-RADS in hepatocellular carcinoma surveillance;Egyptian Journal of Radiology and Nuclear Medicine;2023-08-15

2. Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population;BMC Cancer;2022-06-28

3. Tumor enhancement ratio with unenhanced imaging is an independent prognostic factor for patients with hepatocellular carcinoma after transarterial chemoembolization;Journal of International Medical Research;2021-11

4. Risk factors and screening intervals are crucial for evaluating the cost effectiveness of abbreviated MRI in HCC screening;Journal of Hepatology;2021-11

5. Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2021-05